VELAKAST SOFOSBUVIR VELPATASVIR TABLETS

Get a Price/Quote

VELAKAST SOFOSBUVIR VELPATASVIR TABLETS Specification

Origin of Medicine
India

Pacakaging (Quantity Per Box)
28 tablets per box

Dosage Form
Oral tablet

Salt Composition
Sofosbuvir 400 mg + Velpatasvir 100 mg

Indication
Treatment of adult patients with chronic hepatitis C infection of all genotypes

Drug Type
Allopathic

Ingredients
Sofosbuvir and Velpatasvir

Physical Form
Tablets

Function
Antiviral therapy for HCV

Recommended For
Chronic Hepatitis C Virus (HCV) Infection

Dosage
As directed by physician

Dosage Guidelines
Once daily, orally, with or without food

Suitable For
Adults

Quantity
28 Tablets per bottle

Storage Instructions
Store below 30C, protect from moisture and light

VELAKAST SOFOSBUVIR VELPATASVIR TABLETS Trade Information

Packaging Details
Pack of 28 Tablets

Main Domestic Market
All India

About VELAKAST SOFOSBUVIR VELPATASVIR TABLETS

Velakast Tablets

Specifications:-

Brand Name : VELAKAST
Content: Sofosbuvir &Velpatasvir
Strengths: 400mg + 100mg
Form : Tablets
Packing: Pack of 28 Tablets
Manufactured By: Aprazer

Note :- VELAKAST Is A Prescription Drug And Should Be Used Under Proper Medical Guidance And Advice. Do Not Share The Medicine With Others, Since They May Be Suffering From A Problem That Is Not Effectively Treated By This Drug..............

Comprehensive Antiviral Protection

VELAKAST combines Sofosbuvir and Velpatasvir to address all genotypes of chronic hepatitis C, offering broad-spectrum efficacy. This therapy supports liver health by suppressing viral replication and curbing disease progression. As a convenient once-daily oral tablet, VELAKAST streamlines treatment protocols for adults.

Quality Assurance and Safe Packaging

Manufactured and distributed in India, VELAKAST is supplied in secure plastic bottles containing 28 tablets per box. The product ensures stability through a 24-month shelf life and rigorous protection against moisture and light. These features foster preservation of potency and facilitate safe handling by healthcare providers and patients.

FAQs of VELAKAST SOFOSBUVIR VELPATASVIR TABLETS:

Q: How should VELAKAST Sofosbuvir Velpatasvir Tablets be used for chronic hepatitis C treatment?

A: VELAKAST tablets are intended for oral administration, once daily, with or without food, as prescribed by your physician for chronic hepatitis C infection. It is important to adhere to the recommended dosage and schedule throughout the treatment period.

Q: What are the benefits of using VELAKAST for hepatitis C infection?

A: VELAKAST offers effective antiviral therapy due to its combination of Sofosbuvir and Velpatasvir, targeting all hepatitis C genotypes. This improves treatment outcomes, aids liver function, and reduces the risk of progression to severe liver diseases.

Q: When should VELAKAST not be taken?

A: VELAKAST should not be used by patients with a known hypersensitivity to Sofosbuvir, Velpatasvir, or any excipient in the formulation. It is also not recommended during pregnancy or breastfeeding unless specifically advised by a healthcare professional.

Q: Where should VELAKAST tablets be stored to maintain their effectiveness?

A: To ensure potency, VELAKAST tablets should be stored in their original plastic bottle below 30C, protected from moisture and direct light. Always keep the container tightly closed and away from children.

Q: What is the process for obtaining VELAKAST tablets?

A: VELAKAST is a prescription-only medication; you must consult a healthcare provider to receive a valid prescription. The tablets are distributed, exported, and supplied by authorized dealers in India.

Q: Can VELAKAST be taken by all adults with hepatitis C?

A: VELAKAST is suitable for adult patients diagnosed with chronic hepatitis C across all genotypes but requires medical evaluation for contraindications such as allergies to its ingredients or other health considerations.

Tell us about your requirement